Study guide

3.5 Point of Care Testing and Laboratory Procedures

NHA CCMA Certified Clinical Medical Assistant Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction: NHA CCMA Exam Overview

NHA CCMA Certification Exam Overview Eligibility, Registration & Certification Process Study Strategies & Test-Taking Tips

2 Chapter 1: Foundational Knowledge and Basic Science (10%)

1.1 Medical Terminology 1.2 Healthcare Systems and Settings 1.3 Basic Pharmacology 1.4 Nutrition 1.5 Psychology and Human Behavior 1.6 Math and Measurement for Medical Assistants

3 Chapter 2: Anatomy and Physiology (5%)

2.1 Body Organization & Integumentary System 2.2 Cardiovascular & Respiratory Systems 2.3 Digestive, Endocrine & Nervous Systems 2.4 Musculoskeletal, Urinary & Reproductive Systems 2.5 Common Diseases and Conditions

4 Chapter 3: Clinical Patient Care (56%)

3.1 Vital Signs Assessment 3.2 Patient Intake and Documentation 3.3 General Patient Care Procedures 3.4 Infection Control and Safety 3.5 Point of Care Testing and Laboratory Procedures 3.6 Phlebotomy 3.7 Medication Preparation and Administration 3.8 EKG and Cardiovascular Testing 3.9 Assisting with Specialty Examinations 3.10 Patient Safety and Fall Prevention

5 Chapter 4: Patient Care Coordination and Education (8%)

4.1 Patient Education and Health Literacy 4.2 Care Coordination and Referrals 4.3 Preventive Care and Screening 4.4 Chronic Disease Management and Patient Support

6 Chapter 5: Administrative Assisting (8%)

5.1 Appointment Scheduling and Medical Records 5.2 Billing, Coding, and Insurance 5.3 Financial Management and Practice Operations 5.4 Mail, Correspondence, and Office Equipment

7 Chapter 6: Communication and Customer Service (8%)

6.1 Professional Communication 6.2 Customer Service in Healthcare 6.3 Teamwork and Professionalism 6.4 Communicating with Special Populations

8 Chapter 7: Medical Law and Ethics (5%)

7.1 HIPAA and Patient Rights 7.2 Medical Ethics and Legal Considerations 7.3 Emergency Preparedness and First Aid 7.4 Workplace Safety and OSHA Compliance

3.5 Point of Care Testing and Laboratory Procedures

Key Takeaways Explain This Topic AI

CLIA-waived tests are simple laboratory tests that medical assistants can perform with minimal training, including glucose monitoring, urine dipstick, rapid strep, and pregnancy tests

Quality control (QC) must be performed according to manufacturer instructions, typically with each new lot number, new reagent, and at regular intervals

Urinalysis includes three components: physical (color, clarity, specific gravity), chemical (dipstick for pH, protein, glucose, blood, etc.), and microscopic (cells, casts, crystals)

Normal fasting blood glucose is 70-100 mg/dL; A1C below 5.7% is normal; results above these ranges may indicate prediabetes or diabetes

Specimen labeling must include patient name, date of birth, date and time of collection, collector's initials, and test ordered

  • Chain of custody procedures are required for drug screening specimens to ensure legal defensibility of results
  • Last updated: March 2026

Point of care testing (POCT) refers to laboratory tests performed at or near the site of patient care, with results available quickly to guide clinical decisions. Medical assistants frequently perform CLIA-waived tests in physician offices and clinics.

CLIA Regulations

The Clinical Laboratory Improvement Amendments (CLIA) regulate all laboratory testing performed on human specimens:

CLIA Category Complexity Who Can Perform Examples

Waived Simple, minimal risk of error Medical assistants, trained staff Glucose meters, urine dipstick, rapid strep, pregnancy tests

Moderate complexity Requires more training Medical laboratory technicians CBC (automated), basic chemistry panels

High complexity Requires specialized training Medical technologists, pathologists Flow cytometry, genetic testing

CLIA-waived tests commonly performed by MAs:

  • Blood glucose monitoring (glucometer)
  • Urine dipstick analysis
  • Urine pregnancy test (hCG)
  • Rapid strep test (Group A Streptococcus)
  • Rapid influenza test
  • Fecal occult blood test (FOBT/iFOBT)
  • Hemoglobin A1C (certain devices)
  • Prothrombin time/INR (certain devices)
  • Rapid COVID-19 antigen test
  • Mononucleosis rapid test
  • Quality Control (QC)

Quality control ensures test results are accurate and reliable:

QC Component Purpose When

Control samples Known-value specimens tested to verify instrument accuracy Each new lot, new reagent, as per manufacturer schedule

  • Calibration Adjusting the instrument to known standards Per manufacturer instructions
  • Proficiency testing External evaluation of lab accuracy Required for moderate/high complexity labs
  • Temperature logs Monitoring refrigerator/freezer temperatures for reagent storage Daily
  • Maintenance logs Documenting instrument maintenance and calibration Per schedule
  • QC log Recording all QC results, actions taken for out-of-range results With each QC run

If QC is out of range:

  • Do NOT report patient results
  • Troubleshoot (check expiration, repeat with new control, recalibrate)
  • Repeat QC
  • Only report patient results when QC is within acceptable range
  • Document all corrective actions
  • Urinalysis

Three Components of a Complete Urinalysis:

1. Physical Examination:

  • Parameter Normal Abnormal
  • Color Pale yellow to amber Red (blood), dark amber (dehydration), cloudy (infection)
  • Clarity Clear Cloudy/turbid (bacteria, WBCs, crystals)
  • Specific gravity 1.005-1.030 High (dehydration), low (overhydration, kidney issues)
  • Odor Mild, slightly aromatic Foul (infection), fruity/sweet (ketones in diabetes)

2. Chemical Examination (Dipstick):

  • Parameter Normal Clinical Significance of Abnormal
  • pH 4.5-8.0 (avg 6.0) Alkaline: UTI; acidic: dehydration, diabetic ketoacidosis
  • Protein Negative Positive: kidney disease, preeclampsia
  • Glucose Negative Positive: diabetes, renal threshold exceeded
  • Ketones Negative Positive: diabetic ketoacidosis, starvation, low-carb diet
  • Blood Negative Positive: UTI, kidney stones, menstrual contamination
  • Bilirubin Negative Positive: liver disease, bile duct obstruction
  • Urobilinogen 0.2-1.0 mg/dL Elevated: liver disease, hemolytic anemia
  • Nitrite Negative Positive: bacterial UTI (gram-negative bacteria)
  • Leukocyte esterase Negative Positive: WBCs present — possible UTI
  • Specific gravity 1.005-1.030 High/low: kidney function, hydration status

3. Microscopic Examination (performed by provider or qualified technician):

  • Red blood cells, white blood cells, epithelial cells
  • Bacteria, yeast
  • Casts (hyaline, granular, cellular)
  • Crystals (uric acid, calcium oxalate)

Blood Glucose Testing

Normal Values:

  • Test Normal Prediabetes Diabetes
  • Fasting blood glucose (FBG) 70-100 mg/dL 100-125 mg/dL ≥126 mg/dL
  • Random blood glucose <140 mg/dL — ≥200 mg/dL (with symptoms)
  • Hemoglobin A1C <5.7% 5.7-6.4% ≥6.5%
  • Oral glucose tolerance test (OGTT) <140 mg/dL (2-hour) 140-199 mg/dL ≥200 mg/dL

Glucose Monitoring Procedure:

  • Verify provider order and patient identity
  • Perform hand hygiene; don gloves
  • Select the puncture site (fingertip — lateral side is less painful)
  • Cleanse with alcohol; allow to air dry completely (alcohol can affect results)
  • Puncture with a lancet
  • Wipe away the first drop of blood (contains tissue fluid that dilutes the sample)
  • Apply the second drop to the test strip
  • Record the result and report abnormal values to the provider

Hypoglycemia (<70 mg/dL): Symptoms include shakiness, sweating, confusion, irritability, rapid heartbeat Hyperglycemia (>200 mg/dL): Symptoms include excessive thirst, frequent urination, fatigue, blurred vision

Common Laboratory Tests and Normal Values

  • Test Normal Range Clinical Significance
  • WBC 4,500-11,000/μL Elevated: infection, inflammation; Low: immunosuppression
  • RBC M: 4.7-6.1; F: 4.2-5.4 million/μL Low: anemia; High: polycythemia
  • Hemoglobin M: 14-18 g/dL; F: 12-16 g/dL Low: anemia
  • Hematocrit M: 42-52%; F: 37-47% Low: anemia; High: dehydration
  • Platelet count 150,000-400,000/μL Low: bleeding risk; High: clotting risk
  • BUN 7-20 mg/dL Elevated: kidney dysfunction, dehydration
  • Creatinine 0.7-1.3 mg/dL Elevated: kidney dysfunction
  • Total cholesterol <200 mg/dL Elevated: cardiovascular risk
  • LDL ("bad") <100 mg/dL Elevated: cardiovascular risk
  • HDL ("good") >40 mg/dL (M); >50 mg/dL (F) Low: cardiovascular risk
  • Triglycerides <150 mg/dL Elevated: cardiovascular risk
  • TSH 0.4-4.0 mIU/L High: hypothyroidism; Low: hyperthyroidism
  • PT/INR PT: 11-13.5 sec; INR: 0.8-1.2 Monitors warfarin therapy; INR goal typically 2.0-3.0
  • Specimen Collection and Handling
  • Specimen Collection Method Special Instructions
  • Clean-catch urine Midstream specimen after cleansing Cleanse perineal area; catch midstream portion
  • 24-hour urine All urine collected over 24 hours Discard first void; collect all subsequent; keep refrigerated
  • Stool (FOBT) Small sample on test card Avoid red meat, vitamin C, NSAIDs for 3 days before

Throat swab Swab tonsillar area and posterior pharynx Avoid touching tongue or cheeks; patient should not eat/drink 30 min prior

  • Wound culture Swab from wound bed Clean wound first; swab the active border, not the center
  • Sputum Cough specimen into sterile container Early morning, deep cough; rinse mouth first

Specimen Labeling Requirements: All specimens must be labeled with:

  • Patient's full name
  • Date of birth
  • Date and time of collection
  • Collector's initials
  • Test ordered
  • Source/site (if applicable)